Introduction
A number of recent studies have suggested that the kidney may not be unique in metabolizing 25-hydroxyvitamin D3 (250HD3)' to 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). The placenta (1) (2) (3) , bone cells (4, 5) , and possibly embryonic intestinal cells (6) produce a metabolite from 250HD3 with the chromatographic properties of 1,25(OH)2D3. Likewise, sarcoid tissue or cells (7, 8) and melanoma cells (9) produce a metabolite thought to be 1,25(OH)2D3. Whether such cells and tissues produce 1,25(OH)2D3 in vivo is unclear. Acutely nephrectomized rats fail to convert 250HD3 to detectable amounts of 1,25(OH)2D3 (10, 11) ; anephric patients in one study had undetectable 1 ,25(OH)2D3 levels ( 12). Detectable levels ofthis metabolite were recently reported in an anephric patient with sarcoidosis (13) , however, and in other anephric patients and anephric pigs given high doses of vitamin D (14, 15) . Therefore, anephric humans and pigs may be able to produce 1,25(OH)2D3 in tissues other than the kidney, especially when circulating 250HD3 and parathyroid hormone (PTH) concentrations are high.
The skin is a likely alternate source for 1,25(OH)2D3 because previous investigations have shown that in addition to synthesizing vitamin D3 (16, 17) , the skin can synthesize 24,25(OH)2D3 (18) . Furthermore, the skin is well established as a target tissue for 1,25(OH)2D3 because it contains receptors for 1,25(OH)2D3 (19) as well as 1,25(0H)2D3-regulated functions such as vitamin D3 production and keratin synthesis (18, (20) (21) (22) (23) . Production of 1,25(OH)2D3 by the skin, therefore, could serve not only a systemic need in times of reduced production of 1,25(OH)2D3 by the kidney, but also a local need in regulating the unique epidermal functions of vitamin D production and keratin synthesis.
In recent studies we have observed that human foreskin keratinocytes (but not fibroblasts) produce 1,25(OH)2D3 (24) . Identification was based on its elution pattern in several different high performance liquid chromatography (HPLC) systems, its potency in displacing [3H] 1,25(OH)2D3 from the intestinal cytosol receptor for 1,25(OH)2D3, and its mass spectrum. We present evidence here indicating that the production of 1,25(OH)2D3 by keratinocytes is regulated by substrate (250HD3) availability, PTH, and 1,25(OH)2D3 in a fashion somewhat similar to the regulation of 1,25(OHf)2D3 production by the kidney but with several important differences. These data support the hypothesis that the skin may be an important source of this metabolite, not only for use by the epidermis, but also by the rest of the body when renal production of 1,25(OH)2D3 is impaired.
Methods
Cells. Human newborn foreskins were obtained at circumcision. Keratinocytes were isolated by treatment with trypsin and collagenase and plated onto a monolayer of mitomycin C-treated feeder 3T3 cells in Dulbecco's modified Eagle's medium containing 20% fetal calf serum, penicillin, streptomycin, and amphotericin B, according to the method of Rheinwald and Green (25) . Immediately prior to assay, feeder cells were removed from the cultures with 0.1% EDTA. Second or third passage cells were studied after they achieved confluence. All experiments were done on keratinocyte cultures within 1 or 2 d of reaching confluence. At this stage, a few 3T3 cells (<5%) remained attached to the dish under the overlying, multilayered islands of keratinocytes. The relative numbers of 3T3 cells and keratinocytes were ascertained by fluorescence microscopy of cultures after treatment with 1 mg/fll of acridine orange (pH 7.0). Whereas acridine orange labeled the cytosol and nuclei of 3T3 cells orange to red, keratinocytes were easily distinguished by their greenstaining cytosol. Moreover, ultrastructural studies on these cultures revealed that virtually all ofthe cells in confluent cultures were keratinocytes with desmosomes and bundles of intermediate filaments.
After achieving confluence, the protein and DNA content of the culture dishes remained stable for at least 9 d. The mean intraassay coefficients of variation for protein and DNA content from three experiments each with six replicate dishes were 9.9 and 7.3%, respectively.
The interassay coefficients of variation for protein and DNA content for these three experiments were 4.7 and 3.6%, respectively. 250HD3 metabolism. Serum-free medium replaced the original medium 40 h prior to the assay of 250HD3 metabolism. In general, 0.1 gCi 25-hydroxy[26,27-methyl-3H]vitamin D3 (148-153 Ci/mmol, Amersham Corp., Arlington Heights, IL) was added to the culture dish (3 cm diam, 1 ml medium) in 10 .ld ethanol. Following the desired period of incubation at 370C under 1 atmosphere (atm) 5% CO2 in air, the reaction was stopped with I ml methanol. For most experiments, cells and medium were extracted together by the method of Bligh and Dyer (26) . The aqueous extract was counted for radioactivity without' further processing. The chloroform extract was chromatographed using a Waters HPLC system (Waters Associates, Milford, MA) equipped with a Radiomatics Flo One HP radioactivity detector, a Dupont Zorbax Sil column (4.6 mm X 25 cm) (E. I. Dupont, Wilmington, DE), and a Waters Systems controller to deliver a nonlinear (program 9) gradient from 97:3 to 90:10 hexane/isopropanol at 2 ml/min. The radioactivity monitor determined radioactivity at 6-s intervals, plotted the peaks, summed the radioactivity within each peak, and expressed each sum as a fraction of the total radioactivity in each sample. The results were converted to femtomoles of metabolite per well, based on the specific activity and the amount of [3H]250HD3 originally added to the incubate. This calculation assumes that each metabolite formed has the same specific activity as the substrate. This assumption would not be valid if tritium loss occurred (as would happen for the production of 25,26-dihydroxyvitamin D3 using the 26,27-labeled 250HD3 substrate) during the production of the metabolite. Accordingly, for metabolites whose structure is not known, the results must be considered relative and not absolute. Prior to chromatographic analysis of each group of samples, the column was calibrated with the standards 250HD', 24(R), 25 (29) . All other chemicals were reagent grade and were obtained from commercial suppliers.
Results
The addition of [3H]250HD3 to human keratinocytes resulted in rapid uptake (or binding) of radioactivity by the cells that was maximal by 1 h ofincubation (Fig. 1) . After 1 h, the radioactivity Peaks eluting at these times were minor or nonexistent in this experiment, although in other experiments a substantial peak eluting in the position of 1,24,25(OH)2D3 was observed (see description below). This peak also was periodate sensitive. The unidentified metabolites are referred to as peaks 22, 24, 27, and 28 according to their elution time in minutes in this chromatographic system. The amount of these metabolites recovered from the cells and the medium depended on the duration of the incubation as shown in Fig. 4 . A metabolite in peak 22 rapidly appeared in the medium, reaching a peak at 15 min, followed by an exponential decay over the next 24 h. A second metabolite may have appeared in peak 22, increasing in the cell more slowly and reaching a maximum level at 4 h before disappearing by 24 h. The metabolite 1,25(OH)2D3 was found in greatest concentration 1 h after the addition of 250HD3. Very little 1,25(OH)2D3 was released into the medium. The amount of peak 24 in the cells and in the medium increased in parallel (although the cells contained more at all times), reaching a maximum concentration 8 h after the addition of 250HD3. Peak 27 also increased in parallel in both cells and medium, reaching a maximum con- The substrate dependence of 1,25(OH)2D3 production was determined using a 1-h incubation and a total 250HD3 concentration from 0.65 X 10-9 M (tracer only) to 500 X 10-9 M. The results analyzed by an Eadie-Hofstee plot (Fig. 5) (Fig. 7) . At the lowest dose tested (10- As the concentration of exogenous 1,25(OH)2D3 increased, the The apparent Km of the I a-hydroxylase in keratinocytes for 250HD3 was found to be 5.4 X 10-8 M. This value is within the range reported in two studies for the Ia-hydroxylase in primary renal cell cultures-1.3 X 10-8 M (30) and 12.5 X 10-8 M (31)-and below that reported for freshly isolated renal cell tubules and mitochondria, 32 X 10-8 M (32) . In all these preparations the apparent Km is only an estimate of the true Km because of the finite amount of time required to transport the substrate (250HD3) to the enzyme, and because the product (1 ,25(OH)2D3) continued to be metabolized. Ifone assumes that these estimates are reasonable approximations of the true Ki, and if only the free 250HD3 concentration in blood is available to the la-hydroxylase (which we have measured as 0.015% of the total 250HD3, or 15 pM in normal individuals, manuscript in preparation), then the la-hydroxylase in kidney and skin should be undersaturated and able to produce 1,25(OH)2D3 almost linearly as the available 250HD3 substrate is increased. However, this does not seem to occur in vivo in normal individuals, suggesting that the la-hydroxylase is regulated by mechanisms other than the substrate availability.
PTH, 1,25(OH)2D3, and calcium are well-established regulators of 1,25(OH)2D3 production by the kidney in vivo. The effects of calcium on 1,25(OH)2D3 production by intact renal cells in vitro have been subtle (30) (31) (32) , so our failure to demonstrate an effect of extracellular calcium on the production of 1,25(OH)2D3 by keratinocytes was not unexpected. Perhaps the extracellular calcium concentration had little influence on the intracellular calcium concentration in these experiments. However, a number of studies have reported that PTH stimulates 1,25(OH)2D3 production by intact renal cells in vitro (30, 31, (33) (34) (35) (36) (37) . Stimulation ofthe renal la-hydroxylase in these reports required 2-200 ng/ml PTH, the same concentration range that increased the amount of 1,25(OH)2D3 in keratinocytes incubated with 250HD3. IBMX, a potent phosphodiesterase inhibitor, also increased the amount of 1,25(OH)2D3 recovered from the keratinocytes despite our inability to demonstrate an effect of cAMP. The increase in recoverable 1,25(OH)2D3 in cells incubated with IBMX and PTH was greater if the IBMX and PTH were added 4 h before the 4-h incubation with 250HD3. This result contrasts with our results in freshly isolated renal cells and slices (34, 35) in which the maximal effect of PTH was acute; however, in other studies using cultured renal cells, the effects of PTH on 1,25(OH)2D3 production also required several hours (30, 31, 36 
